292 related articles for article (PubMed ID: 7525850)
1. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.
Karin N; Mitchell DJ; Brocke S; Ling N; Steinman L
J Exp Med; 1994 Dec; 180(6):2227-37. PubMed ID: 7525850
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
3. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis.
Ruiz PJ; Garren H; Hirschberg DL; Langer-Gould AM; Levite M; Karpuj MV; Southwood S; Sette A; Conlon P; Steinman L
J Exp Med; 1999 Apr; 189(8):1275-84. PubMed ID: 10209044
[TBL] [Abstract][Full Text] [Related]
4. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
Aharoni R; Teitelbaum D; Arnon R; Sela M
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
[TBL] [Abstract][Full Text] [Related]
5. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.
Mustafa M; Vingsbo C; Olsson T; Ljungdahl A; Höjeberg B; Holmdahl R
Eur J Immunol; 1993 Dec; 23(12):3089-95. PubMed ID: 7504988
[TBL] [Abstract][Full Text] [Related]
6. Short peptide-based tolerogens without self-antigenic or pathogenic activity reverse autoimmune disease.
Karin N; Binah O; Grabie N; Mitchell DJ; Felzen B; Solomon MD; Conlon P; Gaur A; Ling N; Steinman L
J Immunol; 1998 May; 160(10):5188-94. PubMed ID: 9590272
[TBL] [Abstract][Full Text] [Related]
7. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
Martin R
J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells.
Xiao BG; Huang YM; Xu LY; Ishikawa M; Link H
J Neuroimmunol; 1999 Jun; 97(1-2):25-36. PubMed ID: 10408975
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.
Tselios T; Daliani I; Probert L; Deraos S; Matsoukas E; Roy S; Pires J; Moore G; Matsoukas J
Bioorg Med Chem; 2000 Aug; 8(8):1903-9. PubMed ID: 11003134
[TBL] [Abstract][Full Text] [Related]
11. MHC class II peptide flanking residues of exogenous antigens influence recognition by autoreactive T cells.
Conant SB; Swanborg RH
Autoimmun Rev; 2003 Jan; 2(1):8-12. PubMed ID: 12848969
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
13. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
14. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog.
Stepaniak JA; Gould KE; Swanborg RH
J Neurosci Res; 1996 Aug; 45(4):447-54. PubMed ID: 8872905
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis.
Muhallab S; Lundberg C; Gielen AW; Lidman O; Svenningsson A; Piehl F; Olsson T
Scand J Immunol; 2002 Mar; 55(3):264-73. PubMed ID: 11940233
[TBL] [Abstract][Full Text] [Related]
16. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system.
Vandenbark AA; Vainiene M; Celnik B; Hashim G; Offner H
J Neuroimmunol; 1992 Aug; 39(3):251-60. PubMed ID: 1379608
[TBL] [Abstract][Full Text] [Related]
17. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
[TBL] [Abstract][Full Text] [Related]
18. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
19. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
Samson MF; Smilek DE
J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes.
Offner H; Vainiene M; Gold DP; Celnik B; Wang R; Hashim GA; Vandenbark AA
J Immunol; 1992 Mar; 148(6):1706-11. PubMed ID: 1371785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
